Literature DB >> 19217673

Statin therapy in the elderly: a review.

Iwona Szadkowska1, Adam Stanczyk, Wilbert S Aronow, Jan Kowalski, Lucjan Pawlicki, Ali Ahmed, Maciej Banach.   

Abstract

Cardiovascular morbidity is the leading cause of mortality in the developed nations. Elevated serum cholesterol is a major risk factor for ischemic heart disease, one of the common cardiovascular morbidity in older adults, statins have been shown to be effective in reducing serum cholesterol and improving outcomes. Hypercholesterolemia is common in older adults and is one of the major modifiable risk factors. Yet, these patients have often been excluded from major clinical trials of statins and evidence suggests of their underuse. Data from recent clinical trials of statins indicate that the elderly patients with the highest cardiovascular risk are likely to derive the most benefits from cholesterol lowering. With the aging of the population, the prevalence of hypercholesterolemia and cardiovascular morbidity is likely to increase. In this review we evaluate the evidence for the use of statins in older adults.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19217673     DOI: 10.1016/j.archger.2008.12.012

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  19 in total

1.  My legs are getting old: sinvastatin-induced polyneuropathy.

Authors:  Einstein Francisco Camargos; Larissa de Freitas Oliveira; Thaís de Deus Vieira Boaventura
Journal:  BMJ Case Rep       Date:  2011-03-03

2.  Older peoples' attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia.

Authors:  Katie Qi; Emily Reeve; Sarah N Hilmer; Sallie-Anne Pearson; Slade Matthews; Danijela Gnjidic
Journal:  Int J Clin Pharm       Date:  2015-06-06

Review 3.  Current drug treatment of hyperlipidemia in older adults.

Authors:  Dave L Dixon; Krista L Donohoe; Kelechi C Ogbonna; Sarah M Barden
Journal:  Drugs Aging       Date:  2015-02       Impact factor: 3.923

Review 4.  Myopathy in older people receiving statin therapy: a systematic review and meta-analysis.

Authors:  Roli B Iwere; Jonathan Hewitt
Journal:  Br J Clin Pharmacol       Date:  2015-07-22       Impact factor: 4.335

5.  Physiologically Based Pharmacokinetic Modelling to Identify Pharmacokinetic Parameters Driving Drug Exposure Changes in the Elderly.

Authors:  Felix Stader; Hannah Kinvig; Melissa A Penny; Manuel Battegay; Marco Siccardi; Catia Marzolini
Journal:  Clin Pharmacokinet       Date:  2020-03       Impact factor: 6.447

6.  Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study.

Authors:  Marco Bertolotti; Carlotta Franchi; Marco B L Rocchi; Andrea Miceli; M Vittoria Libbra; Alessandro Nobili; Giulia Lancellotti; Lucia Carulli; Chiara Mussi
Journal:  Drugs Aging       Date:  2017-04       Impact factor: 3.923

7.  Prescribing omissions in elderly patients admitted to a stroke unit: descriptive study using START criteria.

Authors:  Elisabete Pinto Borges; Manuel Morgado; Ana Filipa Macedo
Journal:  Int J Clin Pharm       Date:  2012-04-12

8.  The impact of statin therapy on long-term cardiovascular outcomes in an outpatient cardiology practice.

Authors:  Hoang M Lai; Wilbert S Aronow; Anthony D Mercando; Phoenix Kalen; Harit D Desai; Kaushang Gandhi; Mala Sharma; Harshad Amin; Trung M Lai
Journal:  Med Sci Monit       Date:  2011-12

9.  Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies.

Authors:  Kamal Awad; Maged Mohammed; Mahmoud Mohamed Zaki; Abdelrahman I Abushouk; Gregory Y H Lip; Michael J Blaha; Carl J Lavie; Peter P Toth; J Wouter Jukema; Naveed Sattar; Maciej Banach
Journal:  BMC Med       Date:  2021-06-22       Impact factor: 8.775

Review 10.  Muscular effects of statins in the elderly female: a review.

Authors:  Shilpa Bhardwaj; Shalini Selvarajah; Eric B Schneider
Journal:  Clin Interv Aging       Date:  2013-01-18       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.